Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

TV-1106

Recombinant protein · Agonist of Growth Hormone Receptor (GHR) · developed by Teva Branded Pharmaceutical Products R&D

Phase 2 Most advanced trial (none active)
TEVA Developer
1 Registered trials

What is TV-1106?

TV-1106 (albutropin) is a recombinant human growth hormone used to treat growth hormone deficiency. It is studied in patients with dwarfism and pituitary disorders.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
albutropin
Drug type
Recombinant protein
Targets
Growth Hormone Receptor (GHR)
Mechanism
Agonist of Growth Hormone Receptor (GHR)
Pathways
growth and metabolism, IGF-1 signaling
Therapy area
Endocrine
Developer
Teva Branded Pharmaceutical Products R&D, Inc. (TEVA)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2
UNII
88C1D8R8JW

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT02092077 Phase 2 Growth Hormone-Deficiency Terminated TEVA

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Growth Hormone-Deficiency

Other drugs acting on GHR

Lonapegsomatropin FDA approved Somatropin FDA approved

More from Teva Branded Pharmaceutical Products R&D

Omacetaxine Mepesuccinate FDA approved Laquinimod Phase 2 TL011 Phase 1

Sources

Updated Oct 3, 2026. Something wrong or missing? Report it on the TEVA page.

Follow TEVA, the company behind TV-1106

See TEVA's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

TEVA catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.